KBLB fairy tale breadcrumbs...
*Files Form 8-A and secures $1M Bridge Financing towards NASDAQ Uplist
•Kraig Labs has developed its first immune-enhancing genetic insert, designed to create disease-resistant silkworms.
•Generation II Spider Silk Technology- Essentially pure spider silk.
•Generation III Spider Silk Technology- More specific customization.
•The Company’s knock-in knock-out technology allows Kraig Labs to work with very complex protein sequences in silkworm, which are about four times more complex than published technologies.
•Dr. Trevor Kane, the Company’s Chief Scientific Officer, stated that his team is already working on producing even larger, more complex, constructs, based on the Darwin’s bark spider.
•Ambitious immunity boosting program will benefit not only the Company’s proprietary transgenics, but will help strengthen production for mundane silk market, which is a $5 billion a year industry.
•The New Technology, which is the result of over ten years of effort, hits the target of one of the Company’s primary technological goals and opens the door for large scale US production
•Preparing to fulfill material deliveries to numerous end markets that we are targeting for growth in 2020
•2019 brought us the beginning of production operations, perhaps the most significant milestone in the Company’s work to commercialize spider silk since the creation of the first transgenics.
•Kraig Biocraft Laboratories officially transitioned into the increased production and scalability phase of our operations. This operational focus will serve as the foundation in creating and maintaining long-term shareholder value. We are preparing to expand our footprint and deliver our largest ever commercial production of spider silk.
•Established Prodigy Textiles Ltd., our wholly owned Vietnamese subsidiary, which has been granted authorization and business licenses to open recombinant spider silk production operations.
•Signed a development agreement with a market leader in high performance textiles, to create the next generation of non-woven protective fabrics using spider silk.
•Secured a factory in Vietnam, to produce our recombinant spider silk, and signed agreements with suppliers and service providers to support growth.
•Produced the first sample of woven Dragon Silk fabric.
•Successfully completed a first of its kind, international shipment of transgenic silkworms.
•Established and staffed the Company’s first standalone R&D headquarters.
•Created new transgenics with the potential to surpass our existing technologies.
•Implemented new processes rapidly accelerating the pace of new transgenic development.
•Expanded our intellectual property position with additional provisional patent filings.
•Implemented new production quality control systems in preparation for rapid expansion.
*On July 18, 2016, we announced the opening of our first international office located in Vietnam.
*On July 12, 2016, we announced our first U.S. Army contract with whom we will be developing the next generation in soldier protective materials.
*On May 24, 2016, we announced that we completed the biosafety and project risk assessment for our planned operations and subsidiary in Vietnam. These documents were prepared in response to a request from the Vietnamese government to help them better understand the new technology the Company plans to introduce.
*On May 16, 2016, we announced that the Company is planning on establishing more than one additional production location, including domestic operations, that would produce in parallel to its planned operations in Vietnam.
*On May 10, 2016, we announced the development of 4 new transgenic silkworm lines. These new transgenics are based on a new set of the Company’s most complex protein designs to date. The Company believes that these new transgenics have the potential to produce silk fibers with an unprecedented combination of physical properties with the potential to rival its existing Dragon SilkTM line.
*On February 29, 2016, we announced the signing of a cooperative agreement with a governmental entity in Vietnam to develop and produce the Company’s advanced silk technologies. Under the terms of the agreement Kraig Labs agreed to form a subsidiary company in Vietnam and to open an advanced hybrid silk research and pilot production operation.
*On September 30, 2015, Future Materials Magazine is featured the Company in an article titled “Strong as Silk”, as well as on the magazine’s cover.
*On September 22, 2015, we were named as a finalist in three categories for Internationale Textilmaschinen Ausstellung’s (“ITMA”) Future Materials Awards 2015.The categories were in ‘Most innovative small company’, ‘Best innovation, protective textile’, and ‘Best innovation, sustainable textile.’
*On August 19, 2015, we announced the development of our strongest silk to date, Dragon Silk™ and filed two additional patents, in conjunction with the University of Notre Dame, to strengthen its intellectual property protection surrounding its transgenic silkworms and spider silk technologies.
*On June 15, 2015, we announced that after a series of meetings with Vietnam’s central and regional governments, the Company has signed a memorandum of understanding (MOU). Pursuant to the MOU, Kraig Labs and the Vietnamese provincial government will jointly develop a cooperative plan for the development and production of Kraig Labs trangenics in Vietnam.
*On January 21, 2015, Kraig Labs announced it hired a new COO Jon Rice, who will be responsible for all new product development and commercialization.
*On September 23, 2014, we announced ITMA selected Kraig Biocraft Laboratories for its “most innovative small business” and “best innovation” future material awards.
*On September 10, 2014, we announced Textile World Magazine featured Monster Silk™ as its “Quality Fabric of the Month”.
*On July 30, 2014, we announced the development and implementation of a new protocol which increased the quality and efficiency of our transgenic selection and breeding process.
*On July 15, 2014, we announced the U.S. Patent and Trademark Office registered our Monster Silk™, Spiderpillar™, and Spilk™ trademarks.
*On July 9, 2014, we announced we successfully doubled our production of Monster Silk™.
*On June 18, 2014, we announced Warwick Mills created the world’s first textile utilizing our genetically engineered spider silk, Monster Silk™.
*On May 29, 2014, we announced our genetically engineered spider silk, Monster Silk™, production program is thriving and is successfully accommodating a recent significant increase in the scale of production.
*On May 5, 2014, we announced Warwick Mills is preparing to weave the first textiles with our Monster Silk™ recombinant spider silk.
*On April 22, 2014, we announced receiving fiber testing equipment, including customized components, to test latest genetically engineered prototype fiber, Big Red™.
*On March 24, 2014, we announced our genetically engineered spider silk, Monster Silk™, production program has more than doubled in productivity.
*On February 6, 2014, we announced a very successful mission to assess the potential to establish commercial production of our high technology spider silk fibers in Vietnam.
*On January 9, 2014, we announced a meeting with high level Vietnamese government officials, regarding the establishment of genetically engineered spider silk fiber production in Vietnam.
*On October 21, 2013, we announced that we have signed a collaborative development agreement with Warwick Mills, Inc. The signed agreement is concerning the development and commercialization of advanced textiles utilizing our Monster Silk™ genetically engineered spider silk technology.
*On October 7, 2013, we announced the launching of our commercial spider silk production program with the recent hatching of its first batch of Monster Silk™ silkworms for commercial production.
*On September 23, 2013, we announced that the Monster Silk™, genetically engineered spider silk fibers are stronger than the comparable weight of traditional structural steel.
*On September 10, 2013, we announced that the initial testing of our genetically engineered spider silk, Big Red, indicate that is stronger than Monster Silk™.
*On August 19, 2013, we announced that our spider silk pilot production program has successfully produced a sufficient quantity of Monster Silk™ cocoons to make the first Monster Silk™ textile prototypes.
*On July 15, 2013, we announced we are scheduled to start commercial production of our genetically engineered spider silk, Monster Silk™.
*On May 7, 2013, we announced plans to launch the initial commercial production of our spider silk, Monster Silk™.
*On March 19, 2013, we announced that the cocoons from the first stage of the Monster Silk™ pilot production program have been reeled into threads of the genetically engineered spider silk.
*On March 4, 2013, we announced that the silkworm hatchlings from the first stage of our Monster Silk™ pilot production program have spun cocoons. The cocoons are made of Monster Silk™, our genetically engineered spider silk.
*On February 28, 2013, we announced the launch of stage 3 of our spider silk pilot program.
*On February 25, 2013, we announced that the first two stages of our genetically engineered spider silk, Monster Silk™ pilot production program are running ahead of schedule and the both stages of the program are on track to meet or exceed the program’s goals.
*On February 13, 2013, we announced jointly with SSM Industries, Inc. that they have signed a memorandum of understanding to jointly commercialize our genetically engineered spider silk, Monster Silk™.
*On February 4, 2013, we announced that we are accelerating the spider silk pilot production program, as a result of positive initial data from the first stage of the trial.
*On January 28, 2013, we announced that World Textile Information Network (WTiN) recently published an article, entitled, “Commercializing the science of spider silk”, featuring our genetically engineered spider silk technologies.
*On January 22, 2013, we announced our plans for a pilot production program for Monster Silk ™.
*On January 14, 2013, we announced the creation of “Big Red,” a new recombinant spider silk designed for increased strength.
*On January 5, 2012, we announced that the National Academy of Sciences published the peer-reviewed scientific article describing our spider silk breakthrough in the prestigious journal Proceedings of the National Academy of Sciences. Congratulations to our scientific team!
On November 14, 2011, we announced yet another breakthrough: The success of our micro-injections of Sigma-Aldrich’s zinc finger technology, and the creation of seven new strains of ZF transgenics.
*On November 3, 2011, we announced a second landmark with the signing of a commercial Spider Silk licensing agreement with the University of Notre Dame whereby the University became a Kraig shareholder.
*On April 12, 2011, we announced a landmark deal with biotechnology giant Sigma-Aldrich that we believe will pave the way for the future of our company.
*************************************************************************************
DROP-IN AND GO KBLB! HOLDING THE GOLDEN!!!
